Search for Terms or Answers
Dr. Jack Cush reviews the FDA approvals and news reports from this past week on RheumNow.com. This week we discuss playing the numbers in rheumatology, playing the long game with stem cell transplants, and a=the Positive spin on seronegative RA.
For someone who has spent so much of his career recognizing the work of others, it is fitting that Dr. John J. “Jack” Cush should have his own moment in the spotlight.
Infection remains an important threat to patients with autoimmune and inflammatory diseases. Mitigating this risk is a core duty of the rheumatologist—one that requires us to actively educate patients and advocate for timely vaccination strategies. This article reviews important highlights on the session, “Prevention and treatment of Infections in rheumatic diseases” during the APLAR 2026 Congress.
A current review of seronegative RA (SNRA) by D’Onofrio, et al in npj Autoimmunity shows the diverse fate of seronegative RA - which can resolve, persist or become refractory. Clearly dedicated trials of SNRA are needed to better predict.
Is CAR-T a durable long-term strategy in RA? These three Chinese patients now followed to 18mo It's clearly, definitely not for everyone, but some (but not all) patients do seem to get long-term disease remission, long after naive B cells reconstitute ABST0454 #ACR26 @RheumNow https://t.co/JpEyrlrtH5
Pregnancy in Lupus Nephritis and RA: Managing risks and treating to target A significant proportion of patients with rheumatologic disease are of reproductive age, therefore, navigating reproductive health is now widely recognized as a fundamental component of modern https://t.co/cTVvyXBbug
By downloading this material, I acknowledge that it may be used only for personal use and personal education and that I will accredit RheumNow.com as the source and owner of this material. Commercial use or mass reproduction of this material without permission from RheumNow (info@rheumnow.com) is prohibited.
